Nanoencapsulation of a crystalline drug

International Journal of Pharmaceutics

Volumn 298, Issue 2, 2005, Pages 323-327

  Layre, Anne Magali ^a   Gref, Ruxandra ^a   Richard, Joël ^b   Requier, Denis ^b   Chacun, Hélène ^a   Appel, Martine ^a   Domb, Abraham J ^c   Couvreur, Patrick ^a  

^a UNIV PARIS SUD   (France)

^b Ethypharm   (France)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

DSC; Nanoparticles; PLA; Polyanhydrides; Poorly water soluble crystalline drug

Indexed keywords

CRYSTALLIN; LITHOCHOLIC ACID; NANOPARTICLE; POLYLACTIC ACID; SEBACIC ACID;

BINDING AFFINITY; CONFERENCE PAPER; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG LABELING; DRUG SOLUBILITY; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; NANOTECHNOLOGY; PRIORITY JOURNAL;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LACTIC ACID; LIGHT; MOLECULAR WEIGHT; POLYMERS; SCATTERING, RADIATION; SOLUBILITY;

EID: 21344438179     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.02.039     Document Type: Conference Paper

References (11)

1. Alonso, M.J., 1995. Nanoparticulate drug carrier technology microparticulate system for the delivery of proteins and vaccines. In: Cohen, S., Bernstein, H., (Eds.), pp. 203-242.
2. I. Brigger, P. Chaminade, V. Marsaud, M. Appel, M. Besnard, R. Gurny, M. Renoir, and P. Couvreur Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation Int. J. Pharm. 214 2001 37 42
3. S. Clas The importance of characterizing the crystal form of the drug substance during drug development Curr. Opin. Discov. Dev. 6 2003 550 560
4. Y. Dong, and S.-S. Feng Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs Biomaterials 25 2004 2843 2849
5. Fessi, H.C., Devissaguet, J.P., 1992. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles; US Patent 5,118,528.
6. Gref, R., 2003. Surface-engineered nanoparticles as drug carriers. Synthesis, functionalization and surface treatment of nanoparticles. In: Baraton, M.-I., (Ed.), American Scientific Publishers, Stevenson Ranch, California, pp. 233-256.
7. M.Y. Krasko, A. Shikanov, N. Kumar, and A.J. Domb Polyanhydrides with hydrophobic terminals Polym. Adv. Technol. 13 2002 960 968
8. S.Y. Lin, K.S. Chen, and H.H. Ten Protective colloids and polylactic acid coaffecting the polymorphic crystal form and crystallinity of indomethacin encapsuled in microspheres J. Microencap. 16 1999 769 776
9. I. Nikolakakis, K. Kachrimanis, and S. Malamataris Relations between crystallisation conditions and micromeritic properties of ibuprofen Int. J. Pharm. 201 2000 79 88
10. F. Theeuwes, A. Hussain, and T. Higuchi Quantitative analytical method for determination of drugs dispersed in polymers using Differential Scanning Calorimetry J. Pharm. Sci. 63 1974 427 429
11. S.H. Yalkowsky, and T.J. Roseman Solubilization of drug by cosolvents Techniques of Solubilization of Drug 1980 Marcel Dekker New York pp. 91-135